Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic miniMed — GAAP R&D Expense ($M) ($M)
Quarterly figures from Medtronic's filings and investor materials
Latest, Q1 FY27
115
Period ended Jul 31, 2026
Change on a year earlier
-8.0%
125 in Q1 FY26
History
9 quarters
Since Q1 FY25
Sources
2
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | MiniMed — GAAP R&D Expense ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q1 FY27 | Jul 31, 2026 | 115 | -8.0% | MiniMed Group (MMED) 10-Q — 10q_FY2027Q1 (filed 2026-09-08) ↗ |
| Q4 FY26 | Apr 30, 2026 | 99 | -7.5% | MiniMed Group FY2026 Q4 Earnings Presentation ↗ |
| Q3 FY26 | Jan 31, 2026 | 114 | +1.8% | MiniMed Group FY2026 Q4 Earnings Presentation ↗ |
| Q2 FY26 | Oct 31, 2025 | 111 | -0.9% | MiniMed Group FY2026 Q4 Earnings Presentation ↗ |
| Q1 FY26 | Jul 31, 2025 | 125 | +19.0% | MiniMed Group FY2026 Q4 Earnings Presentation ↗ |
| Q4 FY25 | Apr 30, 2025 | 107 | – | MiniMed Group FY2026 Q4 Earnings Presentation ↗ |
| Q3 FY25 | Jan 31, 2025 | 112 | – | MiniMed Group FY2026 Q4 Earnings Presentation ↗ |
| Q2 FY25 | Oct 31, 2024 | 112 | – | MiniMed Group FY2026 Q4 Earnings Presentation ↗ |
| Q1 FY25 | Jul 31, 2024 | 105 | – | MiniMed Group FY2026 Q4 Earnings Presentation ↗ |
Cite this data
StockData. (2026). Medtronic MiniMed — GAAP R&D Expense ($M) ($M), quarterly Q1 FY25–Q1 FY27 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/mmed-sub-gaap-rd
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.